tiprankstipranks
Trending News
More News >
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
India Market

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Financial Statements

Compare
1 Followers

GlaxoSmithKline Pharmaceuticals Limited Financial Overview

GlaxoSmithKline Pharmaceuticals Limited's market cap is currently ₹542.98B. The company's EPS TTM is ₹15.5; its P/E ratio is 58.54; and it has a dividend yield of 113.10%. GlaxoSmithKline Pharmaceuticals Limited is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 37.49B₹ 34.42B₹ 32.52B₹ 32.78B₹ 31.99B
Gross Profit₹ 23.58B₹ 20.22B₹ 19.67B₹ 18.28B₹ 18.04B
Operating Income₹ 17.79B₹ 13.60B₹ 8.39B₹ 7.69B₹ 7.61B
EBITDA₹ 11.77B₹ 8.87B₹ 9.03B₹ 8.49B₹ 5.36B
Net Income₹ 9.28B₹ 5.90B₹ 6.11B₹ 3.81B₹ 3.58B
Balance Sheet
Cash & Short-Term Investments₹ 25.22B₹ 18.57B₹ 18.12B₹ 29.03B₹ 11.37B
Total Assets₹ 41.08B₹ 35.57B₹ 33.27B₹ 46.33B₹ 31.13B
Total Debt₹ 99.50M₹ 186.65M₹ 155.40M₹ 200.76M₹ 346.27M
Net Debt₹ -13.94B₹ -455.06M₹ -194.00M₹ -2.66B₹ -3.71B
Total Liabilities₹ 21.57B₹ 17.79B₹ 15.85B₹ 19.70B₹ 16.14B
Stockholders' Equity₹ 19.51B₹ 17.78B₹ 17.41B₹ 26.63B₹ 14.99B
Cash Flow
Free Cash Flow₹ 12.67B₹ 5.51B₹ 4.40B₹ 7.76B₹ 5.34B
Operating Cash Flow₹ 12.90B₹ 5.82B₹ 4.84B₹ 8.11B₹ 5.78B
Investing Cash Flow₹ -458.10M₹ -847.21M₹ 8.08B₹ -4.06B₹ 4.19B
Financing Cash Flow₹ -7.69B₹ -5.61B₹ -15.43B₹ -5.24B₹ -6.96B
Currency in INR

GlaxoSmithKline Pharmaceuticals Limited Earnings and Revenue History

GlaxoSmithKline Pharmaceuticals Limited Debt to Assets

GlaxoSmithKline Pharmaceuticals Limited Cash Flow

GlaxoSmithKline Pharmaceuticals Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis